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1. Introduction 
Fungal metabolites, ML236A and ML236B 
(Bg.l), have been isolated from cultures of Penicillium 
citinum as potent inhibitors of cholesterol synthesis 
in vitro in this laboratory [l] . 
These metabolites (LD5e for mice > 2 g, per OS) 
cause a marked decrease in serum cholesterol levels 
in rats [l] , and in hens and dogs (Kitano, Tsujita and 
Endo, in preparation). The experiments reported in 
this paper demonstrate that MG236A and ML-236B 
inhibit specifically 3-hydroxy-3-methylglutaryl (HMG)- 
CoA reductase (EC 1 .I .1.34), the rate-limiting enzyme 
in cholesterol synthetic pathway, without affecting 
the rest of the enzymes involved in this pathway, and 
that the inhibition is competitive with respect to the 
substrate HMG-CoA. 
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Fig.1. Structures of ML-236A and ML-236B. 
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2. Materials and methods 
[1-14C]Acetate (59.5 mCi/mmol) and D,L[2-r4C] 
mevalonolactone (27.3 mCi/mmol) were obtained 
from Radiochemical Centre. [ 1 -14C] Acetyl-CoA 
(49.8 mCi/mmol) and D,L[3-r4C]HMG-CoA (26.2 
mCi/mmol) were purchased from New England 
Nuclear. Lactone forms of ML236A and ML-236B 
were prepared as previously described [l] . Acid 
forms (sodium salts) (fig.1) of these compounds were 
prepared by saponification of their respective lactone 
forms in 0.1 N NaOH at 50°C for 2 h. Other chemicals 
were of the best grade commercially available. 
2.1. Incorporation experiments 
Rat liver microsomes and cytosolic enzyme fraction 
were isolated as described previously [2]. The reaction 
mixture (0.2 ml) contained: 1 mM ATP, 10 mM 
glucose-l-phosphate, 6 mM glutathione, 6 mM MgC12, 
40 PM CoA, 0.25 mM NAD, 0.25 mM NADP, 100 mM 
potassium phosphate-buffer (pH 7.4) 0.15 mg protein 
of microsomes, 1.5 mg protein of cytosolic enzyme 
fraction and 1 mM [ I-‘4C]acetate (1.5 mCi/mmol). 
Where indicated, [ 1 -14C] acetate was replaced by 
0.15 mM [l-‘4C]acetyl-CoA (1.0 mCi/mmol), 0.13 mM 
D,L[3-‘4C]HMG-CoA (7.3 mCi/mmol) or 0.52 mM 
D,L [2-14C] mevalonate (1.26 mCi/mmol). After 
incubation at 37°C for 60 mm, the reaction was 
terminated by addition of 1 ml 15% alcoholic KOH. 
The synthesized nonsaponifiable lipids and fatty acid 
were measured as described previously [2]. Under 
these conditions, the incorporations of radiolabeled 
substrates were proportional to time up to 120 min. 
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2.2. HMG-CoA reductase assay 3. Results 
Rat liver microsomes were obtained as described 
previously [2] , from which HMG-CoA reductase was 
solubilized by the method of Heller and Gould [3] 
and partially purified by fractionation with ammonium 
sulfate. The fraction precipitated by 35-50% satura- 
tion was used after dialysis for 3 h against 40 mM 
potassium phosphate buffer, pH 7.2, containing 
100 mM sucrose, 50 mM KCl, 30 mM EDTA and 
1 mM dithiothreitol. The reaction mixture (50 ~1) 
contained: 100 mM potassium phosphate buffer 
(pH 7.4) 10 mM EDTA, 10 mM dithiothreitol, 5 mM 
NADPH, 0.11 mM D,L-[3-r4C]HMG-CoA (1.6 mCi/ 
mmol) and l-2 pg of enzyme protein. After incuba- 
tion at 37°C for 20 min, the reaction was terminated 
by addition of 20 ~1 of 2 N HCl, and the mevalono- 
lactone formed was isolated and counted as described 
previously [2]. The specific activity of the enzyme 
used was lo- 17 nmol of mevalonate formed/min/mg 
protein under standard conditions. 
3.1. Incorporation of radiolabeled substrates into 
lipids 
As reported in a previous paper [l] , MG236B 
lactone is far more inhibitory in the [ l-14C]acetate 
incorporation into nonsaponifiable lipids than ML-236A 
lactone. The inhibitory potency was approximately 
doubled by the conversion of lactone forms to their 
respective acid forms (sodium salts). Of the four 
derivatives tested, ML236B sodium salt was the 
most inhibitory. Concentrations required for 50% 
inhibition of nonsaponifiable lipid synthesis were: 
ML-236A 0.85 PM, ML-236A sodium salt 0.35 PM, 
ML236B lactone 0.026 PM, MG236B sodium salt 
0.014 I.IM (O.OQ6 lug/ml). None of these compounds 
had significant effects on the fatty acid synthesis from 
[14C]acetate at concentrations which caused 50% or 
more reduction in the nonsaponifiable lipid synthesis. 
Protein was determined by the method of Lowry 
et al. [4]. 
Table 1 shows the effects of ML-236B sodium salt 
on the incorporation of various radiolabeled substrates 
into nonsaponifiable lipids. As indicated, conversions 
Table 1 
Inhibitory effects of ML-236B sodium salt on the incorporation of various 
radiolabeled substrates into nonsaponifiable lipids 
Substrate 
ML-236B 
sodium salt 
(nM) 
Incorporation % of control 
dpm/mga 
[ 1-‘C] Acetate None 13 770 
5.0 10 080 
50 4120 
[ l-“‘Cl Acetyl-CoA None 8270 
5.0 6020 
50 2410 
D,L-[ 3-‘4C]HMGCoA None 1050 
5.0 570 
50 270 
D,L-[ 2-“‘CJMevalonate None 35 870 
5.0 34 940 
50 34 180 
73.2 
29.9 
72.8 
29.2 
53.7 
26.0 
97.4 
95.3 
a Counts incorporated/mg protein/60 min. The values for [ 1-“‘Clacetate and 
[l-‘4C]acetyl-CoA were calculated on the assumption that 33% of the radioactivity 
in these substrates were converted into CO, during their incorporation into 
nonsaponifiable lipids. 
Experimental conditions are described in Materials and methods. The results are the 
average of duplicate incubations. 
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of i14C]acetate, [‘4C]acetyl-CoA and D,L-fi4CJHMG- 
CoA were inhibited to similar extent at two concen- 
trations of the agent, 5 nM and 50 nM. On the other 
hand, D,L~~4CJmevalonate conversion into non- 
saponifiable lipids was not affected by MG236B 
sodium saIt at concentrations up to 50 nM, indicating 
that this compound inhibited speci~cally the enzy- 
matic step for the conversion of HMG-CoA to 
mevalonate catalyzed by HMG-CoA reductase. 
3.2. Inhibition ofHMG-CoA reductuse 
As shown in fig.2, all the four compounds were 
inhibitory to HMG-CoA reductase. The acid forms 
(sodium salts) of both ML236A and MC236B were 
more effective in inhibiting the reductase than their 
respective lactone forms, and the two forms of ML- 
236B were more potent inhibitors than those of 
ML236A. Concentrations required for 50% i~ibition 
were: ML236A lactone 3.4 PM, ML236A sodium salt 
1.2 PM, ML-236B lactone 0.10 ELM, ML 236B sodium 
salt 0.023 ,uM. The data correlated well with the 
results obtained for the inhibition of nonsaponi~abie 
lipid synthesis from [14C]acetate, although igher 
concentrations of the compounds were required for 
in~bition of the reductase. 
The in~bition of HMG-CoA reductase by these 
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Fig.2. Inhibition of HMGCoA reductase by ML-236A and 
ML236B. Experiments were carried out as described in 
Materials and methods. The results are expressed as % of 
control (without inhibitor). The value for control was 16.5 
nmol/min/mg protein. 
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Fig.3. Double reciprocal plots of the inhibition of HMGCoA 
reductase by ML-236B sodium salt. Experiments were carried 
out as described in Materials and methods, except that con- 
centrations of HMGCoA (A) and NADPH (B) were varied as 
indicated. 
compounds was competitive with respect o HMG-CoA 
and noncompetitive with respect o NADPH (fig.3). 
The Ki values were: ML236A sodium salt 0.22 PM, 
ML236B sodium.salt 0.010 yM. Under these condi- 
tions, Km values for the two substrates were: D,L 
HMG-CoA 33 PM, NADPH 40 PM. 
4. Discussion 
The ~-methylbutyrate r sidue of ML-236B 
(fig.1) appears to play a signi~cant role in the inhibi- 
tion of HMG-CoA reductase activity, since both 
lactone and acid forms of ML236A, lacking such a 
residue in their structure, are far less i~bito~ than 
ML236B analogs. The acid forms of both ML-236A 
and ML236B contain a portion having a chemical 
structure very similar to that of 3-hydroxy-3-methyl- 
glutarate (fig.1). This is compatible with the fact that 
these compounds are competitive inhibitors of HMG- 
CoA reductase (competitive against HMG-CoA) and 
further that the acid forms are more potent than the 
corresponding lactone forms. The present results, 
considered together with those given in the previous 
paper [ 1 ] , provide good evidence that a specific 
inhibitor of HMG-CoA reductase iseffective in reducing 
cholesterol synthesis in viva, and thereby in lowering 
cholesterol levels in blood. 
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